{
  "personality": null,
  "timestamp": "2025-09-04T04:38:40.249522",
  "category": "Health",
  "news_summary": "Today's health news highlights groundbreaking advances in medical science, including innovative uses of DNA-embedded viruses, cutting-edge technology to repair nerves and brain function, new insights into metformin’s health benefits, and progress in mosquito control methods.",
  "news_summary_fr": "L'actualité sanitaire d'aujourd'hui met en lumière les avancées révolutionnaires de la science médicale, notamment l'utilisation novatrice de virus incorporés à l'ADN, une technologie de pointe pour réparer les nerfs et les fonctions cérébrales, de nouvelles connaissances sur les bienfaits de la metformine pour la santé et des progrès dans les méthodes de lutte contre les moustiques.",
  "news_summary_es": "Las noticias sanitarias de hoy destacan avances revolucionarios de la ciencia médica, como los usos innovadores de virus con ADN, la tecnología punta para reparar nervios y funciones cerebrales, los nuevos conocimientos sobre los beneficios de la metformina para la salud y los avances en los métodos de control de mosquitos.",
  "articles": [
    {
      "title": "Hidden viruses in our DNA could be medicine’s next big breakthrough",
      "summary": "Scientists have decoded the 3D structure of an ancient viral protein hidden in our DNA. The HERV-K Env protein, found on cancer and autoimmune cells, has a unique shape that could unlock new diagnostics and therapies.",
      "content": "You are mostly but not entirely human. If we crunch the numbers, 8 percent of your genome actually comes from viruses that got stranded there. This viral detritus is a souvenir from our evolutionary past, a reminder that viruses have been with us from the very beginning.\n\nUsually, this 8 percent of your DNA -- the viral bits -- are kept silent. Scientists call it part of the \"dark matter\" in your genome.\n\nNow scientists at La Jolla Institute for Immunology (LJI) have published a first look at a key viral protein. In a study published in Science Advances, LJI researchers revealed the first three-dimensional structure of a protein from one of these ancient \"human endogenous retroviruses (HERVs).\"\n\nThe team mapped the surface envelope glycoprotein (Env), the antibody target of the most active HERV, marking a milestone in structural biology. \"This is the first human HERV protein structure ever solved -- and only the third retroviral envelope structure solved overall, after human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV),\" says Erica Ollmann Saphire, Ph.D., MBA, LJI President, CEO, and Professor.\n\nThis discovery opens the door to new strategies for diagnosing and treating disease. Back in the evolutionary past, HERV-K Env proteins studded the outside of the HERV-K retroviruses. But in modern humans, HERV-K Env proteins show up on the surface of certain tumor cells and in patients with autoimmune and neurodegenerative diseases, making them a valuable target for developing novel diagnostics and therapies.\n\n\"In many disease states, like autoimmune diseases and cancer, these genes re-awaken and start making pieces of these viruses,\" says Saphire. \"Understanding the HERV-K Env structure, and the antibodies we now have, opens up diagnostic and treatment opportunities.\"\n\nAn unexpected \"twist\"\n\nUntil now, HERV proteins had been invisible. They've proven too mobile -- and too twitchy -- to be seen with even the most sophisticated imaging techniques. Solving the structure of HERV-K Env was especially challenging because the LJI team needed to capture the protein's delicate \"pre-fusion\" state.\n\nEnvelope proteins are full of potential energy -- they're essentially spring-loaded to merge with a host cell to start the infection process. This means pre-fusion proteins are prone to spontaneous switching to their later, post-fusion state. \"You can look at them funny, and they'll unfold,\" says LJI Postdoctoral Fellow Jeremy Shek, who spearheaded the study as co-first author with LJI Postdoctoral Fellow Chen Sun, Ph.D.\n\nTo study the three-dimensional structure of HERV-K Env, the researchers introduced small substitutions to lock the protein's structure in place, while preserving its natural shape. Saphire and her team have used this approach before to reveal the structures of key proteins on Ebola virus, Lassa virus, and more. The researchers also discovered and characterized specific antibodies that helped anchor different versions of the viral proteins.\n\nAfter stabilizing their HERV-K Env structures, the LJI team used a high-resolution imaging technique called cryo-electron microscopy to capture 3D images of HERV-K Env at three key moments: cell surface, in the act of driving infection, and when it locks together with antibodies.\n\nMany viral envelope glycoproteins have a trimer structure, but HERV-K Env is different from anything scientists had seen before, including trimers from other retroviruses. Unlike the shorter, squatter trimers made by HIV and SIV, the HERV-K Env is tall and lean. Further, the protein's fold -- the weaving together of strands and coils that build the working machine -- is unlike any other retrovirus.\n\nA new path for clinical research\n\nThe new LJI study opens the door to using HERV-K Env to our advantage. Understanding the HERV-K Env structure, and how antibodies target it, may prove useful for developing diagnostic tools or new therapeutics.\n\nFor example, many types of cancer cells -- from breast cancers to ovarian cancers -- but not healthy cells, are dotted with HERV-K Env proteins. This means antibodies against HERV could distinguish cancer cells from healthy cells. As Sun explains, scientists could develop cancer immunotherapies that zero in on HERV-K Env to track down tumor cells. \"We can use it as a strategy to specifically target cancer cells,\" says Sun.\n\nPeople with autoimmune diseases such as lupus or rheumatoid arthritis also express HERV-K Env on their cells. Some scientists suspect that patients' immune cells see these strange proteins and think the body is under attack. Just like during a normal viral infection, their B cells start making antibodies against HERV-K Env proteins.\n\n\"Understanding how antibodies recognize these proteins was challenging because there was no structure and precious few good antibodies yet available,\" says Saphire.\n\nSo the LJI team made their own panel of antibodies to reveal how the immune system can target the different subunits of the molecule in all its different shapes. Once scientists understand how these antibody attacks work, they can try to intervene and stop harmful inflammation.\n\nThe scientists also tested the idea that their antibodies may also be useful tools for diagnosing many autoimmune diseases. They used the antibodies to try and hunt down immune cells in samples from patients with rheumatoid arthritis and lupus. When Saphire and her colleagues tagged these antibodies with a molecular flag, they were able to quickly detect HERV-K Env on neutrophils, a type of immune cell that can cause inflammation.\n\n\"These antibodies marked aberrant HERV display on neutrophils from rheumatoid arthritis and lupus patients, but not healthy controls,\" says Saphire.\n\nThe interest in HERVs is quickly growing, and scientists are finding more and more diseases where HERV-K Env crops up. \"We can really pick whatever disease we're interested in and go down that route,\" says Shek.\n\nThese projects may someday advance clinical care -- and our fundamental understanding of human biology. After all, we're all part virus. It's time to get to know that part of ourselves.\n\nAdditional authors of the study, \"Human endogenous retrovirus K (HERV-K) envelope structures in pre- and postfusion by cryo-EM,\" were Elise M. Wilson, Fatemeh Moadab, Kathryn M. Hastie, Roshan R. Rajamanickam, Patrick J. Penalosa, Stephanie S. Harkins, Diptiben Parekh, Chitra Hariharan, Dawid S. Zyla, Cassandra Yu, Kelly C.L. Shaffer, Victoria I. Lewis, Ruben Diaz Avalos, and Tomas Mustelin,\n\nThis study was supported by a Curebound Discovery Grant (13502-01-000-408) and by LJI & Kyowa Kirin, Inc. (KKNA-Kyowa Kirin North America; and a Kirin North America Accelerator Grant [18030-01-000-408]).",
      "url": "https://www.sciencedaily.com/releases/2025/09/250902085154.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2025-09-03",
      "sentiment_score": 0.9,
      "reasoning": "The article reports a significant scientific breakthrough in decoding the 3D structure of an ancient viral protein embedded in human DNA, which has direct implications for developing new diagnostics and therapies for cancer and autoimmune diseases. This discovery has broad potential health benefits and advances fundamental understanding of human biology, meeting the criteria for positive real-world impact, significance, and substance.",
      "category": "Health",
      "personality_title": "Scientists reveal 3D structure of ancient viral protein in human DNA, opening new paths for cancer and autoimmune disease treatment",
      "personality_presentation": "**Context** – About 8 percent of human DNA comes from ancient viruses that infected our ancestors long ago. These viral parts usually stay silent and are sometimes called the 'dark matter' of our genome. Scientists have been curious about these hidden viral proteins because they appear on some cancer and autoimmune disease cells.\n\n**What happened** – Researchers at the La Jolla Institute for Immunology (LJI) successfully mapped the three-dimensional structure of a viral protein called HERV-K Env. This protein is part of an ancient virus embedded in human DNA. Using advanced imaging called cryo-electron microscopy, they captured detailed 3D images of HERV-K Env in different states. To do this, they had to stabilize the protein, which is usually very fragile and changes shape easily.\n\n**Impact** – This is the first time the 3D structure of a human endogenous retrovirus protein has been solved. The shape of HERV-K Env is different from other known viral proteins, which helps scientists understand how it works. Since this protein appears on cancer cells and immune cells involved in diseases like lupus and rheumatoid arthritis, understanding its structure can help develop new ways to detect and treat these diseases. For example, antibodies targeting HERV-K Env could help identify cancer cells or reduce harmful inflammation in autoimmune conditions.\n\n**What's next step** – Scientists plan to use the new knowledge about HERV-K Env to create better diagnostic tools and treatments. They will explore how antibodies can target this protein to find and attack cancer cells or calm the immune system in autoimmune diseases. Further research will also look at other illnesses where this viral protein shows up, expanding its medical potential.\n\n**One-sentence takeaway** – Decoding the 3D structure of an ancient viral protein in human DNA offers promising new ways to diagnose and treat cancer and autoimmune diseases.",
      "personality_title_fr": "Les scientifiques révèlent la structure 3D d'une protéine virale ancienne dans l'ADN humain, ouvrant de nouvelles voies pour le traitement du cancer et des maladies auto-immunes",
      "personality_presentation_fr": "**Contexte** – Environ 8 % de l'ADN humain provient de virus anciens qui ont infecté nos ancêtres. Ces parties virales restent généralement silencieuses et sont parfois appelées la « matière noire » de notre génome. Les scientifiques s'intéressent à ces protéines virales cachées car elles apparaissent sur certaines cellules cancéreuses et dans des maladies auto-immunes.\n\n**Ce qui s'est passé** – Des chercheurs de l'Institut d'immunologie de La Jolla (LJI) ont réussi à cartographier la structure tridimensionnelle d'une protéine virale appelée HERV-K Env. Cette protéine fait partie d'un virus ancien intégré dans l'ADN humain. Grâce à une technique avancée d'imagerie, la cryo-microscopie électronique, ils ont capturé des images 3D détaillées de HERV-K Env dans différents états. Pour cela, ils ont dû stabiliser la protéine, qui est habituellement très fragile et change facilement de forme.\n\n**Impact** – C'est la première fois que la structure 3D d'une protéine rétrovirale endogène humaine est résolue. La forme de HERV-K Env est différente des autres protéines virales connues, ce qui aide les scientifiques à comprendre son fonctionnement. Comme cette protéine apparaît sur les cellules cancéreuses et les cellules immunitaires impliquées dans des maladies comme le lupus et la polyarthrite rhumatoïde, comprendre sa structure peut aider à développer de nouvelles façons de détecter et traiter ces maladies. Par exemple, des anticorps ciblant HERV-K Env pourraient aider à identifier les cellules cancéreuses ou à réduire l'inflammation dans les maladies auto-immunes.\n\n**Prochaine étape** – Les scientifiques prévoient d'utiliser cette nouvelle connaissance pour créer de meilleurs outils de diagnostic et traitements. Ils étudieront comment les anticorps peuvent cibler cette protéine pour repérer et attaquer les cellules cancéreuses ou calmer le système immunitaire dans les maladies auto-immunes. D'autres recherches exploreront aussi d'autres maladies où cette protéine virale apparaît.\n\n**Une phrase clé** – Décoder la structure 3D d'une ancienne protéine virale dans l'ADN humain offre de nouvelles pistes prometteuses pour diagnostiquer et traiter le cancer et les maladies auto-immunes.",
      "personality_title_es": "Científicos revelan la estructura 3D de una proteína viral antigua en el ADN humano, abriendo nuevas vías para tratar el cáncer y enfermedades autoinmunes",
      "personality_presentation_es": "**Contexto** – Cerca del 8 % del ADN humano proviene de virus antiguos que infectaron a nuestros antepasados. Estas partes virales suelen estar silenciosas y a veces se llaman la «materia oscura» del genoma. Los científicos están interesados en estas proteínas virales porque aparecen en algunas células cancerosas y en enfermedades autoinmunes.\n\n**Qué pasó** – Investigadores del Instituto de Inmunología de La Jolla (LJI) lograron mapear la estructura tridimensional de una proteína viral llamada HERV-K Env. Esta proteína forma parte de un virus antiguo integrado en el ADN humano. Usando una técnica avanzada llamada criomicroscopía electrónica, capturaron imágenes 3D detalladas de HERV-K Env en diferentes estados. Para hacerlo, tuvieron que estabilizar la proteína, que normalmente es muy frágil y cambia de forma fácilmente.\n\n**Impacto** – Es la primera vez que se resuelve la estructura 3D de una proteína retroviral endógena humana. La forma de HERV-K Env es diferente a otras proteínas virales conocidas, lo que ayuda a los científicos a entender cómo funciona. Como esta proteína aparece en células cancerosas y en células inmunes relacionadas con enfermedades como lupus y artritis reumatoide, entender su estructura puede ayudar a crear nuevas formas de detectar y tratar estas enfermedades. Por ejemplo, anticuerpos que se dirijan a HERV-K Env podrían identificar células cancerosas o reducir la inflamación en enfermedades autoinmunes.\n\n**Próximo paso** – Los científicos planean usar este conocimiento para desarrollar mejores herramientas de diagnóstico y tratamientos. Explorarían cómo los anticuerpos pueden atacar esta proteína para localizar y combatir células cancerosas o calmar el sistema inmune en enfermedades autoinmunes. También investigarán otras enfermedades donde aparece esta proteína viral.\n\n**Una frase clave** – Descifrar la estructura 3D de una proteína viral antigua en el ADN humano abre nuevas posibilidades para diagnosticar y tratar cáncer y enfermedades autoinmunes.",
      "image_url": "public/images/news_image_Hidden-viruses-in-our-DNA-could-be-medicines-next-.png",
      "image_prompt": "A detailed, warm-toned painting of an abstract DNA double helix woven with delicate, glowing viral protein structures shaped like elegant, tall and slender spirals, surrounded by softly illuminated antibody-like figures gently embracing the viral proteins, set against a calm, neutral background symbolizing the hidden viral elements within human biology and their potential for healing."
    },
    {
      "title": "The futuristic new tech that could bridge broken nerves and mend minds",
      "summary": "From flexible implants to circuits seeded with living cells, a new kind of electronics is starting to produce long-lasting implants with the potential to help everything from paralysis to hearing and vision loss",
      "content": "From flexible implants to circuits seeded with living cells, a new kind of electronics is starting to produce long-lasting implants with the potential to help everything from paralysis to hearing and vision loss\n\nRyan Wills/Adobe Stock\n\nIan Burkhart was on holiday with friends in 2010 when his life changed forever. He dived into shallow water and broke his neck, leaving him paralysed from the shoulders down at the age of 19. “At that point, I was getting assistance with everything,” he says, “even being able to scratch an itch on my forehead.”\n\nA few years later, Burkhart got an experimental brain implant that rerouted nerve impulses around his broken spinal cord to the muscles of his arm. It took time, but eventually he was able to use his hands and arms again – and even play the video game Guitar Hero. All in all, it worked pretty well.\n\nUntil, that is, it didn’t. Because that’s the thing about the implants we use to repair damaged or failing bodies: they don’t last forever. That goes for devices of all kinds, including the 3 million or so pacemakers inside people’s chests worldwide. Rigid, artificial hardware just doesn’t sit well with the soft and squishy human body; eventually, the immune system turns against these foreign materials.\n\nNow, however, a new type of electronics is being developed in labs around the world that might just change all this. The vision is for implants made from materials that bend, flow and even grow alongside our nerves and muscles, helping them to sit more harmoniously inside us. Some are built from soft, tissue-like materials. Others go further and blend living cells with circuitry. Together, they are forging a new class of “living electronics” that aim to not only last much longer, but also to one day help rebuild the body’s lost connections.\n\nWe have known for centuries that electricity and biology are intimately linked. In the 18th century, Italian scientist Luigi Galvani provided the first concrete demonstration by making frog legs twitch with a jolt of charge. Today, we understand the human body runs on subtle electrical impulses that drive everything from heartbeats to wound healing.\n\nFree newsletter Sign up to Health Check Expert insight and news on scientific developments in health, nutrition and fitness, every Saturday. Sign up to newsletter\n\nWhy implants fail\n\nModern implants tap into this circuitry. Pacemakers maintain the heart’s rhythm. Deep brain stimulators send electrical pulses into our brains to alleviate symptoms of Parkinson’s disease. Cochlear implants can stimulate nerves in the inner ear to restore hearing. Efforts are also under way to develop retinal implants that reinstate a person’s sight.\n\nHow well the body copes with these devices varies wildly. Pacemakers are usually tolerated well, lasting up to 15 years until their batteries need to be replaced, but deep brain stimulators generally need to be replaced every three to five years. Burkhart’s experimental brain implant was a record-breaker at the time, lasting an impressive seven years before it had to be removed.\n\nOne company has developed a thin microelectrode array that sits on the brain’s surface, sending it signals without damaging the delicate tissue. Precision Neuroscience\n\nThese implants are all bedevilled by a common problem: the immune system. Most tissues are soft, and rigid electronics can cut through them like a blade, says Jia Liu at Harvard University. Over time, this causes tiny injuries. The immune system responds, inflammation follows and, eventually, scar tissue surrounds the implant, degrading its signal and sometimes forcing its removal. Our tissues constantly writhe around and can change in shape and density as we age, all of which compounds the problems. Stiff devices just can’t keep up, slipping out of place or tearing surrounding tissue, which triggers further immune attacks.\n\nMaking softer implants\n\nOne straightforward fix is to make these implants softer. Several companies have embraced this approach, including Elon Musk’s Neuralink, which makes a thread-like brain implant, and Precision Neuroscience, whose electrode arrays are encased in a soft, film-like polymer that rests on the brain’s surface.\n\nBut Liu’s lab is pushing the envelope further. It has created an electrode thread so soft that it is almost invisible in water, yet tough enough to survive implantation and the harsh chemicals used in manufacturing. Crucially, the device can pack in almost 100 times as many electrodes per thread as Neuralink’s, boosting the amount of data that can be recorded or transmitted. The probe causes minimal immune response, and Liu thinks that could allow it to remain effective for much longer than implants like Burkhart’s. His start-up, Axoft, recently completed a clinical trial demonstrating that the probes could be safely implanted in human brains and record neural information.\n\nBiohybrid implants that grow\n\nStill, softness isn’t the only route to successful implants. Early in her career, Rylie Green at Imperial College London was working on ideas similar to Liu’s. But, in around 2012, she watched a sci-fi show featuring organic space stations that grow arms to connect with docking spaceships. That got her thinking. “Why can’t our devices grow into the tissue?” she says. “Instead of sitting there and waiting for the body to respond, why can’t we have a more proactive device?”\n\nShe and her team have now developed a tiny probe designed to do just that. At its core is a small circular platinum electrode that is coated in a jelly-like hydrogel – a soft, flexible material that can absorb and store fluids, and that feels a lot like biological tissue. Green’s team seeds this with living neurons, which grow branches that connect with the host’s brain tissue, while staying controllable from the device’s electrode. Her group is developing implants to read brain activity or deliver deep stimulation for conditions such as epilepsy or Parkinson’s.\n\nAt the University of Cambridge, George Malliaras is taking a complementary path, having exchanged ideas with Green for years. His approach merges two cutting-edge biomedical fields: bioelectronics and therapies that treat diseases by using stem cells to repair or replace damaged tissues.\n\nThe strategy is much like a Trojan horse. The idea is to cloak the bioelectronics in living cells that can provide a biological camouflage. That way, the implant can not only evade the body’s immune systems, but also merge with existing tissues.\n\nIn a study published in 2023, Malliaras and his team created a flexible, film-like electrode and coated the end with a hydrogel seeded with stem cells. These cells were coaxed into forming muscle tissue and then the cell-coated end was sutured to the severed nerve ending of a rat’s forearm. The use of tissue meant the body wouldn’t reject the implant, says Malliaras, but it also prompted the rat’s neurons to grow into the implanted muscle cells. This biological bridge allowed the team to record electrical activity from the rat’s nerve at a resolution much higher than a standard electrode implant.\n\nThe group is now working on an implant that can bridge the severed nerve completely, not just recording electrical signals, but restoring movement to a paralysed limb. In the long run, Malliaras envisions versions that can transmit signals both ways – sending movement commands out and bringing sensation back in, whether to and from a real limb or a prosthesis. He says the device is about three to five years away from being tested in people.\n\nBut the benefits of biohybrid approaches may go deeper still. Researchers are already experimenting with transplanting stem cells into people with spinal cord injuries or neurodegenerative conditions. These cells can develop into many different types of nerve cells – but how they mature and wire up to other cells is heavily influenced by the body’s internal electrical signals, particularly during early development.\n\nIn adults, those guiding signals are mostly absent, says Malliaras. But biohybrid approaches could help to replicate these signals, and even speed up and control the regenerative process, he says. There is evidence that electrically stimulating stem cells can help guide how they differentiate, migrate and even function in the body.\n\n“We’re using a very limited capability of electronics when we interface with cells today,” says Malliaras. “I can envision bioelectronics 2.0, where you implant the electrode not just to control an existing neuronal system, but using electrical stimulation to rebuild the network and then control it.”\n\nThat could open up the tantalising possibility of going beyond simply working around the kind of injury that Burkhart suffered to actually restoring the broken connections in his body.\n\nRebuilding brains\n\nThe idea is more than just an academic dream. US start-up Science Corporation is dedicating significant resources to building a commercial biohybrid implant that it hopes could someday help repair connections in the most complex organ of all: the brain.\n\nAlongside conventional brain implants and a retinal implant designed to restore sight, the company is developing a new brain implant that it hopes will surpass any silicon chip in terms of the data it can handle.\n\nThe device starts with a honeycomb-like scaffold that nestles on the brain’s surface. In each of its more than 100,000 tiny compartments sits a single neuron that has been genetically engineered to respond to light. Each gap in the honeycomb contains a tiny light source to activate the neuron and an electrode to record signals returned from the brain. Once implanted, the neurons would extend filaments that connect to neurons in the organ.\n\nPacemakers treat abnormal heart rhythms by sending small electrical pulses to cardiac muscles. Cavallini James/BSIP/Universal Images Group\n\nSo far, this device has demonstrated the ability to send basic signals to a rodent’s brain in animal trials. But the long-term hope is that, one day, these individually controllable neurons could create general-purpose implants with many more connections than are currently feasible. Alan Mardinly, Science Corporation’s director of biology, says he doubts that conventional implant technologies will be able to get past a few tens of thousands of connections, but future biohybrid devices could reach the millions.\n\nThat could be transformative. Think of a patient who has a stroke and loses the ability to speak, says Mardinly. This may damage a brain region, but an implanted lattice of neurons, trained with patterned light, could take over its function. “We view it basically as putting brain-computer interfaces on a spectrum with regenerative medicine,” he says.\n\nLiving electronics\n\nBurkhart, who received his implant over a decade ago, has seen the promises and limitations of these experimental brain devices up close. He isn’t won over by all the developments that people like Mardinly say are still a long way off. “I originally had my [device] implanted over 11 years ago,” he says. “If you had asked me then where we’d be now, I would have thought we’d have a lot more success.”\n\nBut Burkhart isn’t sitting on his hands. He has assembled a group of early brain-computer interface (BCI) research participants called BCI Pioneers to ensure that big innovations in the field remain practical and scalable for real users. And he thinks brain implant technology has reached a tipping point, moving out of labs and into people like him.\n\nMeanwhile, at the University of Pennsylvania, Kacy Cullen is working on what may be the boldest concept yet: throwing out the electronics entirely. He is developing what he calls “living electrodes” – devices built wholly from cells and tissue scaffolds, designed to integrate with the brain and function like native neural circuits.\n\n“ These engineered neuronal microtissues could potentially expand the computational capacity of the brain itself “\n\nEach consists of a clump of neurons genetically engineered to respond to light, perched on a slender hydrogel cylinder. The structure is implanted into the brain like a hollow rod, with the neural bundle remaining at the brain’s surface. Over time, these neurons extend long filaments called axons down the tube, connecting with the cells deep in the host’s brain. It is a biological relay that could bridge different brain regions or link the brain to external devices, like prosthetics or computers, all without triggering the immune response that dooms traditional implants.\n\nAnd unlike electrodes made of metal, which can record inputs from only a handful of neurons, each biological cell can form thousands of connections. Different neuron subtypes use distinct neurotransmitters – chemicals that transmit signals – and form different types of junctions between brain cells, known as excitatory or inhibitory synapses, a variety that offers a richness and specificity that silicon can’t rival. This could allow for a much finer level of control and potentially a higher bandwidth for communication to and from the brain via such a device, says Cullen.\n\nBut why stop there? “These engineered neuronal microtissues could potentially expand the computational capacity of the brain itself, effectively adding new layers of information processing to the nervous system,” he says. In theory, that means more than just repairing damaged circuits – it could one day enhance memory or learning.\n\nFor now, though, this remains a distant goal, and the applications are more grounded. Cullen’s lab received a grant from the UK’s Advanced Research and Invention Agency (ARIA) to adapt the technology for Parkinson’s disease. The aim is to rebuild a key neural circuit – the nigrostriatal pathway – that degenerates from the condition, depriving the brain of dopamine, a neurotransmitter.\n\nHis collaborators, led by Flavia Vitale at the University of Pennsylvania, are creating a biosensor that measures dopamine production in real time. This signal would feed into the living electrode, prompting it to adjust the amount of dopamine it produces.\n\nThe approach could have applications beyond Parkinson’s, says lab member Dimitris Boufidis, because many neurological and psychiatric disorders feature similar disruptions to brain circuitry. “You can think of it as bridges connecting different parts of the brain that get destroyed,” he says. “What if we could rebuild these bridges?”\n\nGreen’s team at Imperial has also received funding under the same ARIA grant to create a scaffold, seeded with neuronal stem cells, that can be injected into the brain to repair damaged circuits. Light and electricity will then be used to guide neuron growth and connections. Though an underlying disease could eventually also degrade repaired connections, Green says it is worth it. “At the end of the day, you buy people time and you buy people quality of life,” she says.\n\nHer lab is also exploring whether the same approach could help with traumatic brain injuries and spinal cord damage, like Burkhart’s. “[We’d use] electrical stimulation to drive regeneration and drive connection, rather than bypassing the injury,” she says.\n\nThough Burkhart remains realistic about the time these things can take to reach patients, it is an approach that resonates with him. “If we can get something that allows someone to function the way they were able to function before a disease or injury, and just allowing them to be as independent as possible, that would be a huge benefit for those individuals and society as a whole,” he says.",
      "url": "https://www.newscientist.com/article/2492875-the-futuristic-new-tech-that-could-bridge-broken-nerves-and-mend-minds/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home",
      "source": "New Scientist - Home",
      "published": "2025-09-03",
      "sentiment_score": 0.9,
      "reasoning": "The article reports on significant advances in biohybrid and flexible brain and nerve implants that have the potential to restore lost functions such as movement, hearing, and vision, and to improve quality of life for people with paralysis, neurological disorders, and injuries. The developments have broad implications for many patients worldwide and include detailed descriptions of new technologies, clinical trials, and future applications, demonstrating substantial real-world impact and meaningful progress in medical technology.",
      "category": "Health",
      "personality_title": "New flexible implants blend biology and technology to repair nerves and brain circuits",
      "personality_presentation": "**Context** – Many people suffer from nerve damage or brain injuries that cause paralysis, hearing loss, or vision problems. Traditional implants use hard materials that the body often rejects over time, limiting their usefulness.\n\n**What happened** – Scientists are developing new soft and living implants that can bend, grow, and connect with the body’s nerves and brain cells. These include flexible electrodes, implants seeded with living neurons or stem cells, and devices that can both send and receive signals. Some have already been tested safely in humans, while others are being studied in animals or prepared for clinical trials.\n\n**Impact** – These new implants could last much longer and work better than current devices. They may help people regain movement after paralysis, restore hearing or vision, and even repair brain circuits damaged by stroke or diseases like Parkinson’s. By blending electronics with living tissue, the implants can avoid immune rejection and encourage the body to rebuild connections. This approach might also improve how well treatments work by actively guiding nerve repair.\n\n**What's next step** – Researchers plan to test these implants more in people to prove they are safe and effective. Some aim to create devices that fully restore nerve function or enhance brain capacity. Others want to use electrical signals to control stem cell growth and repair damaged tissue. Over the next few years, these technologies could move from labs into hospitals to help patients with various neurological conditions.\n\n**One-sentence takeaway** – New flexible and living implants are opening the door to longer-lasting, more natural repairs for nerve and brain injuries, offering hope for improved recovery and quality of life.\n",
      "personality_title_fr": "De nouveaux implants flexibles mêlant biologie et technologie pour réparer nerfs et circuits cérébraux",
      "personality_presentation_fr": "**Contexte** – De nombreuses personnes souffrent de lésions nerveuses ou de blessures cérébrales entraînant paralysie, perte d’audition ou de vision. Les implants traditionnels, fabriqués en matériaux rigides, sont souvent rejetés par le corps avec le temps, ce qui limite leur efficacité.\n\n**Ce qui s’est passé** – Des scientifiques développent de nouveaux implants souples et vivants capables de se plier, de croître et de se connecter aux nerfs et aux cellules cérébrales. Il s’agit d’électrodes flexibles, d’implants ensemencés de neurones vivants ou de cellules souches, et d’appareils pouvant envoyer et recevoir des signaux. Certains ont déjà été testés avec succès chez l’humain, d’autres sont en cours d’études animales ou préparés pour des essais cliniques.\n\n**Impact** – Ces nouveaux implants pourraient durer beaucoup plus longtemps et mieux fonctionner que les dispositifs actuels. Ils pourraient aider à retrouver des mouvements après une paralysie, restaurer l’audition ou la vision, et réparer des circuits cérébraux endommagés par un AVC ou des maladies comme Parkinson. En mêlant électronique et tissu vivant, les implants évitent le rejet immunitaire et encouragent la reconstruction des connexions. Cette méthode pourrait aussi améliorer les traitements en guidant activement la réparation nerveuse.\n\n**Prochaine étape** – Les chercheurs prévoient de tester davantage ces implants chez l’humain pour prouver leur sécurité et leur efficacité. Certains souhaitent créer des dispositifs qui restaurent complètement la fonction nerveuse ou augmentent la capacité cérébrale. D’autres veulent utiliser des signaux électriques pour contrôler la croissance des cellules souches et réparer les tissus endommagés. Dans les prochaines années, ces technologies pourraient sortir des laboratoires pour aider les patients atteints de troubles neurologiques.\n\n**Résumé en une phrase** – De nouveaux implants flexibles et vivants ouvrent la voie à des réparations plus naturelles et durables des lésions nerveuses et cérébrales, offrant des perspectives de meilleure récupération et qualité de vie.\n",
      "personality_title_es": "Nuevos implantes flexibles que combinan biología y tecnología para reparar nervios y circuitos cerebrales",
      "personality_presentation_es": "**Contexto** – Muchas personas sufren daños en los nervios o lesiones cerebrales que causan parálisis, pérdida de audición o visión. Los implantes tradicionales usan materiales rígidos que el cuerpo suele rechazar con el tiempo, limitando su utilidad.\n\n**Qué pasó** – Científicos están desarrollando nuevos implantes suaves y vivos que pueden doblarse, crecer y conectarse con los nervios y células del cerebro. Estos incluyen electrodos flexibles, implantes con neuronas o células madre vivas, y dispositivos que pueden enviar y recibir señales. Algunos ya se han probado con seguridad en humanos, otros se estudian en animales o se preparan para ensayos clínicos.\n\n**Impacto** – Estos nuevos implantes podrían durar mucho más y funcionar mejor que los dispositivos actuales. Podrían ayudar a recuperar el movimiento tras una parálisis, restaurar la audición o la visión, e incluso reparar circuitos cerebrales dañados por un accidente cerebrovascular o enfermedades como el Parkinson. Al combinar electrónica con tejido vivo, los implantes evitan el rechazo inmunológico y fomentan que el cuerpo reconstruya conexiones. Este enfoque también podría mejorar los tratamientos al guiar activamente la reparación nerviosa.\n\n**Próximo paso** – Los investigadores planean probar más estos implantes en personas para demostrar que son seguros y efectivos. Algunos buscan crear dispositivos que restauren completamente la función nerviosa o aumenten la capacidad del cerebro. Otros quieren usar señales eléctricas para controlar el crecimiento de células madre y reparar tejidos dañados. En los próximos años, estas tecnologías podrían salir de los laboratorios y ayudar a pacientes con diversas condiciones neurológicas.\n\n**Frase clave** – Nuevos implantes flexibles y vivos abren la posibilidad de reparaciones más naturales y duraderas para lesiones nerviosas y cerebrales, ofreciendo esperanza para una mejor recuperación y calidad de vida.\n",
      "image_url": "public/images/news_image_The-futuristic-new-tech-that-could-bridge-broken-n.png",
      "image_prompt": "A softly glowing network of delicate, flexible circuits intertwined seamlessly with growing neurons and muscle-like fibers, forming a harmonious living bridge that pulses gently with warm light, set against a calm, neutral background in natural, muted tones."
    },
    {
      "title": "Metformin’s mysterious metal effect could explain its big health benefits",
      "summary": "Metformin, the world’s most widely used diabetes drug, has long been recognized for its surprising range of benefits beyond lowering blood sugar, from reducing inflammation to lowering cancer risk. Yet its exact mechanism has remained unclear for decades. Now, researchers at Kobe University have uncovered the first clinical evidence that the drug alters levels of key metals in the blood.",
      "content": "The widely used diabetes drug metformin changes blood metal levels in humans. The Kobe University study is an important step in understanding the drug's many actions and designing better ones in the future.\n\nMetformin is the most widely prescribed diabetes drug in the world. Apart from lowering blood sugar levels, it is also known to have a broad range of beneficial side effects such as against tumors, inflammations and atherosclerosis. However, although it has been used for more than 60 years now, its mechanism of action is still not clear, hampering the development of even better drugs against these conditions.\n\nKobe University endocrinologist Wataru Ogawa says: \"It is known that diabetes patients experience changes in the blood levels of metals such as copper, iron and zinc. In addition, chemical studies found that metformin has the ability to bind certain metals, such as copper, and recent studies showed that it is this binding ability that might be responsible for some of the drug's beneficial effects. So, we wanted to know whether metformin actually affects blood metal levels in humans, which had not been clarified.\" To do so, Ogawa and his team enlisted about 200 diabetes patients at Kobe University Hospital, half of which took metformin and half of which did not, in a study to analyze their blood serum levels for those metals and various metal deficiency indicators.\n\nIn the journal BMJ Open Diabetes Research & Care, the Kobe University team now published the first clinical evidence of altered blood metal levels in patients taking metformin. They showed that drug-taking patients have significantly lower copper and iron levels and heightened zinc levels. Ogawa says: \"It is significant that we could show this in humans. Furthermore, since decreases in copper and iron concentrations and an increase in zinc concentration are all considered to be associated with improved glucose tolerance and prevention of complications, these changes may indeed be related to metformin's action.\"\n\nRecently, Japan has approved the use of imeglimin, a new diabetes drug that is a derivative of metformin but that should not be able to bind metals the same way as its parent. \"Imeglimin is thought to have a different method of action, and we are already conducting studies to compare the effects the two drugs have,\" says Ogawa.\n\nIt is not just about understanding the current drugs, however. Ogawa explains the bigger picture, saying: \"We need both clinical trials and animal experiments to pinpoint the causal relationship between the drug's action and its effects. If such studies progress further, they may lead to the development of new drugs for diabetes and its complications by properly adjusting the metal concentrations in the body.\"\n\nThis research was funded by the Japan Society for the Promotion of Science (grant 24H00638) and the Manpei Suzuki Diabetes Foundation. It was conducted in collaboration with a researcher from the Kagayaki Diabetes and Endocrinology Clinic Sannomiya.",
      "url": "https://www.sciencedaily.com/releases/2025/09/250903075202.htm",
      "source": "Latest Science News -- ScienceDaily",
      "published": "2025-09-03",
      "sentiment_score": 0.85,
      "reasoning": "The article reports a significant scientific breakthrough providing the first clinical evidence explaining how metformin, a widely used diabetes drug, alters blood metal levels, which may underlie its broad health benefits. This understanding has broad implications for improving diabetes treatment and developing new drugs, benefiting a large patient population worldwide.",
      "category": "Health",
      "personality_title": "Study reveals how diabetes drug metformin changes blood metal levels",
      "personality_presentation": "**Context** – Metformin is the most commonly used medicine for diabetes. It helps lower blood sugar and is known to have other health benefits, like reducing inflammation and lowering the risk of cancer. But scientists have not fully understood how it works.\n\n**What happened** – Researchers at Kobe University studied about 200 diabetes patients. Half were taking metformin, and half were not. They measured metals like copper, iron, and zinc in their blood. They found that people taking metformin had lower copper and iron levels but higher zinc levels.\n\n**Impact** – This is the first clear evidence in humans that metformin changes metal levels in the blood. These metal changes are linked to better blood sugar control and fewer diabetes complications. This discovery helps explain how metformin works beyond just lowering sugar.\n\n**What's next step** – Scientists will compare metformin with a new diabetes drug called imeglimin, which works differently and may not affect metals the same way. They also plan more studies to understand exactly how changing metal levels helps patients. This could lead to better medicines for diabetes and its complications.\n\n**One-sentence takeaway** – New research shows metformin changes blood metal levels, shedding light on how it helps diabetes patients beyond lowering blood sugar.",
      "personality_title_fr": "Une étude révèle comment le médicament metformine modifie les niveaux de métaux dans le sang",
      "personality_presentation_fr": "**Contexte** – La metformine est le médicament le plus utilisé contre le diabète. Elle aide à faire baisser le taux de sucre dans le sang et a d’autres bienfaits, comme réduire l’inflammation et le risque de cancer. Mais on ne comprenait pas encore bien comment elle agit.\n\n**Ce qui s’est passé** – Des chercheurs de l’Université de Kobe ont étudié environ 200 patients diabétiques. La moitié prenait de la metformine, l’autre moitié non. Ils ont mesuré les niveaux de cuivre, fer et zinc dans leur sang. Ils ont constaté que ceux qui prenaient la metformine avaient moins de cuivre et de fer, mais plus de zinc.\n\n**Impact** – C’est la première preuve claire chez l’humain que la metformine modifie les niveaux de métaux dans le sang. Ces changements sont liés à une meilleure gestion du sucre et moins de complications du diabète. Cette découverte aide à comprendre comment la metformine agit au-delà de la baisse du sucre.\n\n**Prochaine étape** – Les scientifiques vont comparer la metformine à un nouveau médicament, l’imeglimine, qui fonctionne différemment et pourrait ne pas modifier les métaux de la même façon. Ils prévoient aussi d’autres études pour mieux comprendre comment ces changements de métaux aident les patients. Cela pourrait conduire à de meilleurs traitements du diabète.\n\n**Résumé en une phrase** – Une nouvelle recherche montre que la metformine modifie les niveaux de métaux dans le sang, ce qui explique comment elle aide les patients diabétiques au-delà de la baisse du sucre.",
      "personality_title_es": "Estudio revela cómo la metformina cambia los niveles de metales en la sangre",
      "personality_presentation_es": "**Contexto** – La metformina es el medicamento más usado para la diabetes. Ayuda a bajar el azúcar en la sangre y tiene otros beneficios, como reducir la inflamación y el riesgo de cáncer. Pero no se entendía bien cómo funcionaba.\n\n**Qué pasó** – Investigadores de la Universidad de Kobe estudiaron a unos 200 pacientes con diabetes. La mitad tomaba metformina y la otra mitad no. Midieron metales como cobre, hierro y zinc en su sangre. Encontraron que quienes tomaban metformina tenían menos cobre y hierro, pero más zinc.\n\n**Impacto** – Esta es la primera evidencia clara en humanos de que la metformina cambia los niveles de metales en la sangre. Estos cambios están relacionados con un mejor control del azúcar y menos complicaciones de la diabetes. Esto ayuda a explicar cómo funciona la metformina más allá de bajar el azúcar.\n\n**Próximo paso** – Los científicos compararán la metformina con un nuevo medicamento llamado imeglimina, que funciona diferente y puede no afectar los metales igual. También harán más estudios para entender cómo estos cambios en los metales benefician a los pacientes. Esto podría llevar a mejores medicinas para la diabetes.\n\n**Resumen en una frase** – Una nueva investigación muestra que la metformina cambia los niveles de metales en la sangre, explicando cómo ayuda a los pacientes con diabetes más allá de bajar el azúcar.",
      "image_url": "public/images/news_image_Metformins-mysterious-metal-effect-could-explain-i.png",
      "image_prompt": "A warm, detailed painting of a glowing human silhouette with stylized blood vessels flowing through, inside which vibrant copper and iron ions gently fade while bright zinc ions rise like luminous orbs, all set against a soft, natural-toned background symbolizing health and scientific discovery."
    },
    {
      "title": "Inside a mosquito factory",
      "summary": "Nature, Published online: 03 September 2025; doi:10.1038/d41586-025-02806-1Brazilian site could produce one kilo of mosquito eggs per week.",
      "content": "Mariana Lenharo is a news reporter for Nature based in New York City.\n\nBrazilian site could produce one kilo of mosquito eggs per week.\n\nYou have full access to this article via your institution.\n\nThere's an unusual factory in Curitiba, Brazil. It's producing mosquitos by the millions, all to combat the diseases these insects spread.\n\nThis is the world’s largest ‘mosquito factory’: its goal is to stop dengue That's because the mosquitos produced here can't spread infections like dengue, zika and chikungunya and can outcompete the wild insects.\n\nSo, what does it take to raise an army of virus fighting mosquitos?\n\nSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.",
      "url": "https://www.nature.com/articles/d41586-025-02806-1",
      "source": "Nature",
      "published": "2025-09-04",
      "sentiment_score": 0.85,
      "reasoning": "The article describes a large-scale, innovative biological intervention to combat mosquito-borne diseases like dengue, zika, and chikungunya by producing sterile or non-infectious mosquitoes that can outcompete wild populations, which has significant positive public health implications for broad populations.",
      "category": "Health",
      "personality_title": "Brazil’s mosquito factory breeds millions to fight disease",
      "personality_presentation": "**Context** – Mosquitoes spread diseases like dengue, zika, and chikungunya, which affect millions of people worldwide. Controlling these diseases is hard because mosquitoes reproduce quickly and live in many places.\n\n**What happened** – In Curitiba, Brazil, a large factory produces millions of special mosquitoes every week. These mosquitoes cannot carry or spread viruses. Instead, they compete with wild mosquitoes, reducing the number of infected insects in the environment. The factory can produce about one kilogram of mosquito eggs each week, which means millions of mosquitoes ready to help.\n\n**Impact** – This is the world’s biggest mosquito factory, and it offers a new way to fight dangerous diseases without using chemicals or sprays. By releasing these safe mosquitoes, the spread of illnesses like dengue could be lowered, helping protect many people from getting sick.\n\n**What’s next step** – Scientists plan to keep releasing these special mosquitoes in different areas to see how well they reduce disease cases over time. If successful, this method could be used in other countries facing similar mosquito problems.\n\n**One-sentence takeaway** – Brazil’s unique mosquito factory produces millions of safe mosquitoes to reduce disease-carrying insects and protect public health.\n",
      "personality_title_fr": "Au Brésil, une usine produit des millions de moustiques pour lutter contre les maladies",
      "personality_presentation_fr": "**Contexte** – Les moustiques transmettent des maladies comme la dengue, le zika et le chikungunya, qui touchent des millions de personnes dans le monde. Il est difficile de contrôler ces maladies car les moustiques se reproduisent vite et vivent partout.\n\n**Ce qui s’est passé** – À Curitiba, au Brésil, une grande usine produit chaque semaine des millions de moustiques spéciaux. Ces moustiques ne peuvent pas porter ni transmettre de virus. Ils rivalisent avec les moustiques sauvages, réduisant ainsi le nombre d’insectes infectés dans la nature. L’usine peut produire environ un kilo d’œufs de moustiques par semaine, soit des millions de moustiques prêts à agir.\n\n**Impact** – C’est la plus grande usine de moustiques au monde, qui offre une nouvelle façon de combattre les maladies dangereuses sans utiliser de produits chimiques ou de sprays. En libérant ces moustiques sûrs, la propagation de maladies comme la dengue pourrait diminuer, protégeant ainsi beaucoup de personnes.\n\n**Prochaine étape** – Les scientifiques prévoient de continuer à libérer ces moustiques spéciaux dans différentes régions pour observer comment ils réduisent les cas de maladie avec le temps. Si cela fonctionne, cette méthode pourrait être utilisée dans d’autres pays avec des problèmes similaires.\n\n**En une phrase** – L’usine unique au Brésil produit des millions de moustiques sûrs pour réduire les insectes porteurs de maladies et protéger la santé publique.\n",
      "personality_title_es": "Fábrica de mosquitos en Brasil cría millones para combatir enfermedades",
      "personality_presentation_es": "**Contexto** – Los mosquitos transmiten enfermedades como el dengue, el zika y el chikungunya, que afectan a millones de personas en todo el mundo. Controlar estas enfermedades es difícil porque los mosquitos se reproducen rápido y viven en muchos lugares.\n\n**Qué pasó** – En Curitiba, Brasil, una gran fábrica produce millones de mosquitos especiales cada semana. Estos mosquitos no pueden portar ni transmitir virus. En cambio, compiten con los mosquitos salvajes, reduciendo el número de insectos infectados en el ambiente. La fábrica puede producir alrededor de un kilo de huevos de mosquito cada semana, es decir, millones de mosquitos listos para ayudar.\n\n**Impacto** – Esta es la fábrica de mosquitos más grande del mundo, y ofrece una nueva forma de combatir enfermedades peligrosas sin usar químicos o aerosoles. Al liberar estos mosquitos seguros, la propagación de enfermedades como el dengue podría disminuir, ayudando a proteger a muchas personas.\n\n**Próximo paso** – Los científicos planean seguir liberando estos mosquitos especiales en diferentes áreas para ver qué tan bien reducen los casos de enfermedad con el tiempo. Si tiene éxito, este método podría usarse en otros países con problemas similares.\n\n**Frase clave** – La fábrica única en Brasil produce millones de mosquitos seguros para reducir los insectos que transmiten enfermedades y proteger la salud pública.\n",
      "image_url": "public/images/news_image_Inside-a-mosquito-factory.png",
      "image_prompt": "A detailed, warm-toned painting of a large, organized indoor space filled with rows of transparent containers gently glowing with clusters of tiny mosquito eggs, surrounded by soft light and subtle silhouettes of mosquitoes in flight, symbolizing a peaceful and hopeful scientific effort to combat disease."
    }
  ]
}